| Literature DB >> 21649903 |
Iná S Santos1, Gicele C Minten, Neiva Cj Valle, Giovana C Tuerlinckx, Alessandra B Silva, Guilherme Ar Pereira, Joaquim F Carriconde.
Abstract
BACKGROUND: Population variation in the duration and amount of menstrual bleeding has received little attention in the literature. This study describes these characteristics and investigates the distribution of self-perceived amount of menstrual bleeding according to socio-demographic, behavioral, and reproductive characteristics.Entities:
Mesh:
Year: 2011 PMID: 21649903 PMCID: PMC3118185 DOI: 10.1186/1472-6874-11-26
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Figure 1Flow chart showing number of women in the waiting rooms and women selected to the study.
Sample distribution and reported intensity of menstruation according to socio-demographic and behavioral characteristics
| Reported intensity menstrual flow | |||||
|---|---|---|---|---|---|
| Variable | N (%) | Heavy | Normal | Light | p |
| Age (years) | <0.001 | ||||
| 18-24 | 204 (23.6) | 68 (33.3) | 100 (49.0) | 36 (17.6) | |
| 25-29 | 159 (18.4) | 36 (22.8) | 70 (44.3) | 52 (32.9) | |
| 30-34 | 171 (19.8) | 57 (33.3) | 67 (39.2) | 47 (27.5) | |
| 35-39 | 149 (17.2) | 61 (41.2) | 46 (31.1) | 41 (27.7) | |
| 40-45 | 182 (21.0) | 82 (45.3) | 57 (31.5) | 42 (23.2) | |
| Skin color | 0.2 | ||||
| White | 641 (74.1) | 218 (34.1) | 250 (39.1) | 171 (26.8) | |
| Black/mixed | 224 (25.9) | 86 (38.6) | 90 (40.4) | 47 (21.1) | |
| Marital status | 0.2 | ||||
| Married/with a partner | 625 (72.3) | 218 (35.0) | 240 (38.5) | 165 (26.5) | |
| Single | 155 (17.9) | 48 (31.0) | 70 (45.2) | 37 (23.9) | |
| Divorced, widowed | 84 (9.7) | 38 (45.2) | 30 (35.7) | 16 (19.0) | |
| Income (MW)1 | 0.5 | ||||
| ≤ 1 | 181 (21.0) | 69 (38.3) | 66 (36.7) | 45 (25.0) | |
| 1.01-2.0 | 355 (41.1) | 130 (36.7) | 145 (41.0) | 79 (22.3) | |
| 2.01-3.0 | 168 (19.5) | 55 (32.7) | 63 (37.5) | 50 (29.8) | |
| > 3 | 159 (18.4) | 50 (31.4) | 65 (40.9) | 44 (27.7) | |
| Education level (years) | 0.001 | ||||
| 0-4 | 179 (20.7) | 72 (40.2) | 60 (33.5) | 47 (26.3) | |
| 5-8 | 394 (45.6) | 153 (38.9) | 137 (34.9) | 103 (26.2) | |
| ≥9 | 291 (33.7) | 79 (27.2) | 143 (49.3) | 68 (23.4) | |
| Weekly alcohol consumption | 0.1 | ||||
| No | 773 (89.5) | 277 (35.9) | 307 (39.8) | 187 (24.3) | |
| Yes | 91 (10.5) | 27 (29.7) | 33 (36.3) | 31 (34.1) | |
| Smoking | 0.1 | ||||
| No | 409 (47.3) | 134 (32.8) | 180 (44.1) | 94 (23.0) | |
| Former smoker | 172 (19.9) | 63 (36.6) | 59 (34.3) | 50 (29.1) | |
| Yes | 283 (32.8) | 107 (37.9) | 101 (35.8) | 74 (26.2) | |
| Caffeine consumption (mg/day) | 0.7 | ||||
| 0-100 | 201 (23.3) | 68 (34.0) | 81 (40.5) | 51 (25.5) | |
| 100.1-200.0 | 272 (31.5) | 88 (32.4) | 107 (39.3) | 77 (28.3) | |
| 200.1-300.0 | 163 (18.9) | 59 (36.4) | 65 (40.1) | 38 (23.5) | |
| > 300 | 228 (26.4) | 89 (39.0) | 87 (38.2) | 52 (22.8) | |
| History of anemia | 0.05 | ||||
| No | 265 (30.7) | 86 (32.6) | 97 (36.7) | 81 (30.7) | |
| Yes | 599 (69.3) | 218 (36.5) | 234 (40.3) | 137 (22.9) | |
| BMI2 | 0.008 | ||||
| ≤ 24.9 | 461 (53.7) | 156 (33.9) | 192 (41.7) | 112 (24.3) | |
| 25.0-29.9 | 237 (27.6) | 74 (31.2) | 102 (43.0) | 61 (25.7) | |
| ≥ 30.0 | 161 (18.7) | 73 (45.6) | 44 (27.5) | 43 (26.9) | |
1MW = Minimum Wages; 2BMI: Body Mass Index;
Sample distribution and reported intensity of menstruation according to reproductive and menstrual characteristics
| Reported intensity menstrual flow | |||||
|---|---|---|---|---|---|
| Characteristic | N (%) | Heavy | Normal | Light | p |
| 304 (35.3) | 340 (39.4) | 218 (25.3) | |||
| Age at menarche (years) | 0.8 | ||||
| ≤ 10 | 73 (8.5) | 32 (43.8) | 26 (35.6) | 15 (20.5) | |
| 11-12 | 363 (42.2) | 128 (35.4) | 143 (39.5) | 91 (25.1) | |
| 13-14 | 330 (38.3) | 109 (33.1) | 134 (40.7) | 86 (26.1) | |
| ≥ 15 | 95 (11.0) | 32 (33.7) | 37 (38.9) | 26 (27.4) | |
| Number of pregnancies | <0.001 | ||||
| 0 | 96 (11.1) | 23 (24.0) | 46 (47.9) | 27 (28.1) | |
| 1-3 | 603 (69.8) | 197 (32.7) | 251 (41.6) | 155 (25.7) | |
| ≥ 4 | 165 (19.1) | 84 (51.5) | 43 (26.4) | 36 (22.1) | |
| Number of abortions | 0.3 | ||||
| 0 | 588 (76.6) | 215 (36.6) | 233 (39.7) | 139 (23.7) | |
| ≥1 | 180 (23.4) | 66 (36.9) | 61 (34.1) | 52 (29.1) | |
| Contraceptive method currently in use1 | <0.001 | ||||
| None | 26 (3.2) | 14 (53.9) | 6 (23.1) | 6 (23.1) | |
| Pill | 416 (51.5) | 102 (24.5) | 177 (42.6) | 137 (32.9) | |
| IUD | 44 (5.5) | 25 (56.8) | 10 (22.7) | 9 (20.5) | |
| Tubal ligation | 93 (11.5) | 63 (68.5) | 16 (17.4) | 13 (14.1) | |
| Injectable hormones | 35 (4.3) | 8 (22.9) | 17 (48.6) | 10 (28.6) | |
| Male preservative | 121 (15.0) | 46 (38.3) | 52 (43.3) | 22 (18.3) | |
| Others | 73 (9.0) | 23 (31.5) | 40 (54.8) | 10 (13.7) | |
| Duration of menstrual periods (days) | <0.001 | ||||
| ≤ 3 | 332 (38.4) | 67 (20.2) | 124 (37.5) | 140 (42.3) | |
| 4 | 197 (22.8) | 50 (25.4) | 104 (52.8) | 43 (21.8) | |
| ≥ 5 | 335 (38.8) | 187 (56.0) | 112 (33.5) | 35 (10.5) | |
| Extra-menstrual bleeding | 0.001 | ||||
| No | 788 (91.2) | 262 (33.3) | 320 (40.7) | 204 (26.0) | |
| Yes | 76 (8.8) | 42 (55.3) | 20 (26.3) | 14 (18.4) | |
| Presence of blood clots | <0.001 | ||||
| No | 398 (46.2) | 98 (24.6) | 181 (45.5) | 119 (29.9) | |
| Yes | 464 (53.8) | 206 (44.4) | 159 (34.3) | 99 (21.3) | |
1Currently pregnant (n = 35) and women at menopause (n = 19) excluded
Prevalence ratios (PR) with 95% confidence intervals (95%CI) for reported heavy menstrual bleeding
| Level | Variable | Crude PR (95% CI) | p | p | |
|---|---|---|---|---|---|
| 1 | Age (years) | 0.0006 | 0.0008 | ||
| 18-24 | 1 | 1 | |||
| 25-29 | 0.68 (0.48-0.97) | 0.67 (0.47-0.94) | |||
| 30-34 | 1.00 (0.75-1.33) | 0.98 (0.73-1.31) | |||
| 35-39 | 1.24 (0.94-1.63) | 1.19 (0.90-1.57) | |||
| 40-45 | 1.36 (1.06-1.75) | 1.31 (1.02-1.69) | |||
| 1 | Education level (years) | 0.0014 | 0.005 | ||
| 0-4 | 1 | 1 | |||
| 5-8 | 0.97 (0.78-1.20) | 1.01 (0.82-1.26) | |||
| ≥9 | 0.67 (0.52-0.88) | 0.71 (0.55-0.92) | |||
| 2 | BMI2 | 0.006 | 0.01 | ||
| ≤ 24.9 | 1 | 1 | |||
| 25.0-29.9 | 0.92 (0.73-1.15) | 0.90 (0.72-1.13) | |||
| ≥ 30.0 | 1.35 (1.09-1.66) | 1.29 (1.04-1.59) | |||
| 3 | Number of pregnancies | <0.0014 | 0.0014 | ||
| 0 | 1 | 1 | |||
| 1-3 | 1.36 (0.94-1.99) | 1.20 (0.81-1.77) | |||
| ≥ 4 | 2.15 (1.46-3.17) | 1.58 (1.02-2.43) | |||
| 3 | Contraceptive method currently in use3 | <0.001 | <0.001 | ||
| Pill/Injectable hormones | 0.64 (0.51-0.82) | 0.66 (0.52-0.84) | |||
| IUD | 1.50 (1.10-2.04) | 1.36 (0.99-1.87) | |||
| Tubal ligation | 1.81 (1.45-2.25) | 1.59 (1.25-2.01) | |||
| Preservative/other methods/none | 1 | 1 | |||
| 4 | Duration of menstrual periods (days) | <0.0014 | <0.0014 | ||
| ≤ 3 | 1 | 1 | |||
| 4 | 1.25 (0.91-1.73) | 1.21 (0.88-1.67) | |||
| ≥ 5 | 2.77 (2.19-3.50) | 2.27 (1.80-2.87) | |||
| 4 | Extra-menstrual bleeding | <0.001 | 0.03 | ||
| No | 1 | 1 | |||
| Yes | 1.66 (1.33-2.07) | 1.28 (1.01-1.63) | |||
| 4 | Presence of blood clots | <0.001 | <0.001 | ||
| No | 1 | 1 | |||
| Yes | 1.80 (1.48-2.20) | 1.44 (1.18-1.76) |
1Confounder control was carried out for variables in the same level and variables in higher levels; 2BMI: Body Mass Index; 3Currently pregnant (n = 35) and women at menopause (n = 19) excluded; 4test for linear trend